Carrieri, Maria Patrizia <br/><br/>
Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial).  [electronic resource] 

 -  The patient  10 2017 
 - 605-614 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1178-1661 
<br/><br/><label>Standard No.: </label>10.1007/s40271-017-0232-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Aged<br/>Antiviral Agents--administration & dosage<br/>Benzimidazoles--administration & dosage<br/>Cohort Studies<br/>Comorbidity<br/>Double-Blind Method<br/>Female<br/>Fluorenes--administration & dosage<br/>Health Status<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Male<br/>Mental Health<br/>Middle Aged<br/>Oligopeptides--therapeutic use<br/>Patient Reported Outcome Measures<br/>Polyethylene Glycols<br/>Proline--analogs & derivatives<br/>Quality of Life<br/>Severity of Illness Index<br/>Sex Factors<br/>Sofosbuvir<br/>Sustained Virologic Response<br/>Uridine Monophosphate--administration & dosage